story of the week
Pen-Administered Low-Dose Dasiglucagon vs Usual Care for the Prevention and Treatment of Non-Severe Hypoglycaemia in People With Type 1 Diabetes During Free-Living Conditions
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Diabetologia
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Pen-administered low-dose dasiglucagon vs usual care for prevention and treatment of non-severe hypoglycaemia in people with type 1 diabetes during free-living conditions: a Phase II, randomised, open-label, two-period crossover trial
Diabetologia 2023 Jul 01;66(7)1208-1217, C Laugesen, AG Ranjan, S Schmidt, K NørgaardFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.